Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
Roche raises profit forecast, plans major U.S. investment amid ongoing drug pricing talks.
Liverpool bounce back with a resounding Champions League win after players' meeting, but injuries mar the victory.
Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
Roche raises profit forecast, plans major U.S. investment amid ongoing drug pricing talks.
Liverpool bounce back with a resounding Champions League win after players' meeting, but injuries mar the victory.